Discontinued — last reported Q3 '21
Idexx Laboratories Deferred contract costs increased by 6.3% to $187.71M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.5%, from $135.57M to $187.71M. Over 5 years (FY 2020 to FY 2025), Deferred contract costs shows an upward trend with a 11.1% CAGR.
An increase suggests high investment in new long-term client engagements, while a decrease may indicate lower new business activity or accelerated amortization.
These represent costs incurred to fulfill a contract that are expected to be recovered over a period exceeding one year....
Common in IT services and consulting firms; peers often report this as 'Contract Acquisition Costs' or 'Deferred Implementation Costs'.
non_current_assets_deferred_costs| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $108.32M | $108.95M | $109.39M | $108.37M | $106.73M | $105.00M | $107.21M | $107.97M | $110.13M | $111.00M | $114.85M | $113.74M | $131.94M | $130.45M | $134.90M | $135.57M | $151.03M | $167.26M | $176.58M | $187.71M |
| QoQ Change | — | +0.6% | +0.4% | -0.9% | -1.5% | -1.6% | +2.1% | +0.7% | +2.0% | +0.8% | +3.5% | -1.0% | +16.0% | -1.1% | +3.4% | +0.5% | +11.4% | +10.7% | +5.6% | +6.3% |
| YoY Change | — | — | — | — | -1.5% | -3.6% | -2.0% | -0.4% | +3.2% | +5.7% | +7.1% | +5.3% | +19.8% | +17.5% | +17.5% | +19.2% | +14.5% | +28.2% | +30.9% | +38.5% |